Thermo Fisher Scientific Inc. (TMO) NYSE
462.60
-6.60999(-1.41%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
462.60
-6.60999(-1.41%)
Currency In USD
Address
168 Third Avenue
Waltham, MA 02451
United States of America (the)
Phone
781 622 1000
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
125000
First IPO Date
March 17, 1980
| Name | Title | Pay | Year Born |
| Marc N. Casper | Chairman & CEO | 6.24M | 1968 |
| Lisa Britt | Chief Human Resources Officer & Senior Vice President | 1.21M | 1968 |
| Thomas Bailey Shropshire Jr. | Senior Vice President and General Counsel | 1.76M | N/A |
| Alan J. Malus | Senior Vice President of Strategy & Corporate Development | 1.77M | 1960 |
| Gianluca Pettiti | President, COO & President of Products and Technologies | 2.42M | 1979 |
| James Meyer | Senior Vice President & Chief Financial Officer | 3.01M | 1980 |
| Stephen Williamson | Senior Vice President & Chief Financial Officer | 3.01M | 1967 |
| Michel Lagarde | Executive Officer | 3.32M | 1975 |
| Karen E. Nelson | Chief Scientific Officer | 0 | N/A |
| Joseph R. Holmes | Vice President & Chief Accounting Officer | 0 | 1980 |
| Ryan J. Snyder | Senior Vice President & Chief Information Officer | 0 | N/A |
| Rafael Tejada | Vice President of Investor Relations | 0 | N/A |
| Sandy Pound | Vice President & Chief Communications Officer | 0 | N/A |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.